Paper - WANFANG MED ONLINE

You Position: Home > Paper

The current research status of genetics of sporadic clear renal cell carcinoma

( views:343, downloads:20 )

Author:: No author available

Journal Title:: CANCER RESEARCH AND CLINIC

Issue:: 4

DOI:: 10.3760/cma.j.issn.1006-9801.2007.04.001

Key Word:: 肾肿瘤;腺癌,透明细胞;遗传学研究

Abstract：散发性肾透明细胞癌的发生机制十分复杂,不同于遗传性肾癌的单一遗传因素起着决定性作用,但3p缺失、VHL的基因突变等遗传学改变,可能会帮助临床进行肾癌病理亚型的鉴别诊断,基因表达谱中分析的一些标志物可能帮助预测预后.

Reference

[1]龚侃,张志文,辛殿旗,等.原发性散发性肾透明细胞癌患者癌组织中抑癌基因VHL突变的研究[J].2001,(3).
[2]Gonzalgo M. L..Molecular Profiling and Classification of Sporadic Renal Cell Carcinoma by Quantitative Methylation Analysis[J].2004.
[3]F, Jiang,R, Desper,C H, Papadimitriou,etc.Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data.[J].2000,60(22).
[4]Jimsgene, Sanjmyatav,Joerg, Schubert,Kerstin, Junker.Comparative study of renal cell carcinoma by CGH, multicolor-FISH and conventional cytogenic banding analysis.[J].2005,14(5).
[5]Gerharz CD,Ramp U,Caliskan E,etc.FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival.[J].2002,196(4).
[6]Hamano Kiminari,Chino Kenji,Igarashi Hiroshi,etc.Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene in sporadic renal cell carcinoma.[J].2002,167(2 Pt.1).
[7]Farhad, Kosari,Alexander S, Parker,Dagmar Marie, Kube,etc.Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.[J].2005,11(14).
[8]Nakatani Y,Baba M,Moriyama M,etc.VHL Tumor Suppressor Gene Alterations Associated With Good Prognosis in Sporadic Clear-Cell Renal Carcinoma.[J].2002,94(20).
[9]Maynard JH,Parry L,Clifford SC,etc.Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas.[J].2001,85(8).
[10]Francesca Girolami,Ilaria Passerini,Dorotea Gargano,etc.Microsatellite analysis of chromosome 3p region in sporadic renal cell carcinomas[J].2002,8(4).
[11]Phillips JL,Schmidt LS,Pavlovich CP.The genetic basis of renal cell carcinoma.[J].2003,30(3).
[12]Padilla Nash H,Ried T,Pavlovich CP,etc.Patterns of aneuploidy in stage IV clear cell renal cell carcinoma revealed by comparative genomic hybridization and spectral karyotyping.[J].2003,37(3).
[13]Gentle D,Morton DG,Latif F,etc.Analysis of the Birt-Hogg-Dube (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer.[J].2003,40(11).
[14]H, Brauch,G, Weirich,J, Brieger,etc.VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.[J].2000,60(7).
[15]Kuzmin I,Protopopov A,Klein G,etc.The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.[J].2001,98(13).
[16]Iwona, Kardas,Krzysztof, Mrózek,Malgorzata, Babinska,etc.Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.[J].2005,13(5).
[17]Worrell R,Klausner RD,Walther MM,etc.Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor.[J].2003,100(12).
[18]Motzer RJ,Mazumdar M,Bacik J,etc.Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma.[J].1999,17(8).
[19]Kobayashi Kazuki,Baba Masaya,Miura Takeshi,etc.Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters.[J].2002,34(1).
[20]Mulders P,Bleumer I,Oosterwijk E.Tumor antigens and markers in renal cell carcinoma.[J].2003,30(3).
[21]N. EMELIANENKO,A. KASHYAP,A. K. BHARGAVE,etc.Biochemical and molecular markers in renal cell carcinoma: an update and future prospects[J].2005,10(4).
[22]Rohrmann K,Haseke N,Siebels M,etc.Targeted agents for the treatment of advanced renal cell carcinoma.[J].2005,6(7).
[23]Rathmell WK,Godley PA.Renal cell carcinoma.[J].2004,16(3).